Genmab (GMAB)

2,176.0
+43.0(+2.02%)
  • Volume:
    109,679
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    2,121.0 - 2,193.0
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0010272202
  • S/N:65734141

GMAB Overview

Prev. Close
2,133
Day's Range
2,121-2,193
Revenue
9.02B
Open
2,149
52 wk Range
1,946-3,124
EPS
35.99
Volume
109,679
Market Cap
142.56B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
136,311
P/E Ratio
60.47
Beta
1.34
1-Year Change
-7.44%
Shares Outstanding
65,513,550
Next Earnings Date
Aug 10, 2022
What is your sentiment on Genmab?
or
Market is currently closed. Voting is open during market hours.

Genmab News

Genmab Analysis

Genmab Company Profile

Genmab Company Profile

Employees
1136
Market
Denmark

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellNeutral
Technical IndicatorsStrong SellBuyStrong BuyStrong SellSell
SummaryNeutralBuyStrong BuyStrong SellNeutral
  • this stock worths buying for the long term?
    0
    • Target 3620 .. medium/long.Daily chart: https://invst.ly/vjgx1 Weekly chart: https://invst.ly/vjgxu
      0
      • Cup with handle - emminent !!!https://www.proinvestor.com/boards/95471Translate from that site (from danish) into english.
        0
        • NBI might roll over. Risky now
          0
          • 1992 indicative price vs 1901 close dk and 1970 close us
            0
            • 2200 this week possible, imo
              0
          • nice correction - but have more or less only removed dec7jan baboon buys
            0
            • You mean since June last year.. 😊.. Giant sell out...
              0
          • US 1st line approval this evening... 1200+ tomorrow?
            0
            • https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=f7f1738b-beb1-47b2-a9dc-ab402ccd42e9
              0
              • Blackrock now owns 5% of the shares in genmab
                0
                • Interesting to see, if we go beyond 1120 this time...
                  0